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Direct and indirect cost of urea excretion. Urea, the major end product
of protein metabolism in mammals, is the most abundant solute in the
urine. Urea excretion is thought to result from filtration curtailed by some
passive reabsorbtion along the nephron. This reabsorption is markedly
enhanced by vasopressin and slow urinary flow rate (V), the fraction of
filtered urea excreted in the urine (FErca) falling from 6O% at high V
to only 2O% at low V. In concentrated urine, normal urea excretion can
be maintained only if urea filtration is elevated. This can be achieved by
increasing plasma urea concentration (Purca) and/or GFR. We have shown
that both parameters do increase when normal rats are submitted to
chronic alterations in the water intake/vasopressin axis within the normal
range of physiologic regulation. This situation is very similar to that
observed after alterations in protein intake. In both cases more urea needs
to be filtered, either because more of it has to be excreted, or because the
efficiency of its excretion is reduced. A common mechanism is proposed to
explain the rise in GFR observed in the two situations. In summary, our
studies demonstrate that the antidiuretic effects of vasopressin are respon-
sible for a significant elevation of GFR. This GFR adaptation limits the
rise in urea, a favorable effect because urea is not as harmless as usually
thought. However, this hyperfiltration might have deleterious conse-
quences in diseased kidneys.
As stated by Homer W. Smith, "urea is the chief nitrogenous
endproduct of the combustion of protein (in mammals) and, apart
from water, the chief constituent of the urine" [1]. In subjects
consuming a Western-type diet (as well as in laboratory rats), urea
accounts for about half of the total urinary solutes, and urea
excretion ranges from 300 to 600 mmol/day. Urea excreted in the
urine is usually considered to result from filtration through the
glomerulus curtailed by a variable amount of urea passively
reabsorbed along the nephron. Urea, which represents less than
2% of the filtered solutes, becomes '50% of the excreted solutes
and is concentrated 20 to 100 times in urine with respect to
plasma. Because it is the most abundant solute in the urine, the
bulk of water reabsorbed by the kidney to concentrate urine is
actually devoted to the concentration of urea. This concentration
in the urine is thought to occur through a passive mechanism
because no significant active urea secretion has been found in the
mammalian nephron (contrary to the amphibian nephron [2]), in
spite of thorough investigations in the 1970s. (As discussed
elsewhere, a passive secretion of urea might occur in the pars
recta of the proximal tubule [3].) The origin of the osmotic energy
enabling urea concentration is thought to derive from the active
reabsorption of sodium in the thick ascending limb of Henle's
loop, distal tubule, and collecting duct. Because this sodium
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should be reabsorbed anyway to maintain sodium balance, urea
excretion and concentration in the urine is apparently not costly to
the kidney.
This is probably why urea clearance, after being a widely used
indicator of renal function in clinical practice for several decades
[4], and more generally urea handling by the kidney, are not
anymore taken into consideration by nephrologists, except for
evaluating the efficiency of dialysis. Moreover, in most experimen-
tal studies of renal function, urea is usually not present in the
various artificial fluids used to perfuse isolated kidneys or nephron
segments, or for in vitro handling of renal tissue. In studies directly
concerned with the influence of protein intake (or amino acid
infusions) on renal function, no attempts are made to evaluate a
possible link between the rise in GFR and the need to excrete
more urea. The only investigators who remained concerned about
urea in the last two decades are those directly interested in the
understanding of the urinary concentrating mechanism or in its
clinical disturbances. This lack of interest may have hindered the
disclosure of a possible (direct or indirect) influence of urea,
present in increasing concentration along the nephron, on several
other aspects of renal function, as will be illustrated in the
following sections.
Protein intake: Low or high?
The rate of urea synthesis, urea turnover through the body, and
urea handling by the kidney differ widely among mammals
according to the dietary regimen and its influence on the amount
of urea they need to excrete (Fig. 1). (1) In carnivores, most of the
energy supply comes from protein-rich food and, accordingly, the
need to excrete urea is high, urea accounting for about 80% of
urinary solutes. The kidney of the dog (and probably that of other
carnivores) seems to be specially adapted to an efficient urea
excretion because urea clearance per g kidney is much higher than
in rat, rabbit or human ([5] and Fig. 14—15 in [3]). (2) In
herbivores, protein intake is relatively low and nitrogen supply is
only close to the minimum needs. Urea excretion is minimized by
a special inter-organ cycle that enables re-use of urea nitrogen.
Filtered urea is largely reabsorbed along the nephron (probably
by an active mechanism as proposed earlier by Schmidt-Nielsen
[6]), leaving low amounts of urea in the urine. Urea diffuses
passively into the gut where an urease-rich microflora can break
down urea into ammonia and carbon dioxyde. Ammonia can then
be re-used for nitrogen metabolism in the intestinal epithelium
and liver. This has been taken to advantage by substituting urea to
more expensive nutrients in cattle feeds. In this context, it is
interesting to note that UT2, a urea transporter present in the
1598
Bankir et al: The real Cost of urea exCretion 1599
Herbivores
4
Low protein diet
Omnivores Carnivores4.-
High protein diet
Fig. 1. Protein supply and corresponding needs,
according to diet in different mammalian groups.
renal medulla, has also been identified in the colon of the rabbit
(a herbivore) [7] but not in that of the rat (omnivore) [8]. (3) In
omnivores, like humans and rats, urea excretory needs vary widely
according to the proportion of proteins in the total energy supply.
An active urea reabsorption has recently been shown to take place
in the collecting duct of rats fed a low protein diet for several
weeks [9, 10]. It may be assumed that rats in this situation develop
an adaptation that is probably normally present in herbivores.
Other differences among different mammals, relating to frequency
and size of the meals, food intake (and thus excretion of end
products) relative to body wt (6- to 8-fold higher in rats than in
humans), average urinary concentrating capacity, and life span
have been addressed elsewhere [31.
Urea excretion and water conservation
Efficient water conservation is vital in terrestrial animals. The
capacity to produce concentrated urine is thus an essential
function of the mammalian kidney. The "osmotic work" of the
kidney required to concentrate urea in the urine (that is, the
urea-linked free water reabsorption) depends both on the amount
of urea to excrete (Eurea) and on the concentration of urea in
urine relative to plasma (U/P urea ratio = U/Purea). As a result,
both protein intake and urinary concentrating activity (UCA) will
influence the osmotic work of the kidney.
Influence of urinaty concentrating activity on the efficiency of
urea excretion
In 1928, MOller, McIntosh and Van Slyke had already observed
that urinary flow rate (V) influences urea clearance [11]. As
shown in Figure 2, the ratio of urea to creatinine or inulin
clearance (now called fractional excretion, FEurea) declines
sharply in the range of physiological urinary flow rates (indicated
by the double arrow) in both humans and rats. Homer W. Smith
devoted several pages and illustrations to this observation in the
book that became the Bible of nephrologists for at least two
decades [4]. Because of this marked influence: (1) renal patients
were advised to increase their fluid intake to maximize their urea
clearance (Curea); and (2) evaluation of renal function in patients,
based mainly on urea clearance, before creatinine and inulin were
introduced as GFR markers, was always made during water
diuresis to abolish the influence of inter-individual variations in
urinary flow rate [4].
In the "Smithian Era" [12], the flow-dependent decrease of
FEurea was considered to result from passive "backdiffusion" of
urea as the urine was progressively concentrated in the distal
nephron and the contact time increased [4]. What was still
unknown at that time was that vasopressin, in addition to its effect
on water permeability in the collecting duct (CD), also increased,
by a V2-mediated action, the permeability to urea in the terminal
part of the CD in the deep inner medulla, thus further enhancing
urea reabsorption [13, 14].
Why reabsorb urea when this solute needs to be excreted? The
vasopressin-dependent urea reabsorption in the terminal CD does
not serve the purpose of urea excretion, but is related to water
conservation. Bringing a concentrated urea solution to the inter-
stitium of the deep inner medulla enhances the local osmotic
pressure, thus enabling more intense osmotically-driven water
reabsorption. This explains why, within certain limits [15], "urea,
but no other solute, enables an economy of water," as was
elegantly observed by Gamble et a! in 1934 [16].
The delivery of concentrated urea to the tip of the papilla would
not be very efficient if urea was rapidly taken up by the ascending
venous vasa recta (in which the flow rate of blood is several times
faster than that of the fluid in the loops of Henle and CD) and
returned to the general circulation. The unique anatomical ar-
rangement of vessels and nephron segments in the medulla, and
the permeability characteristics of the different parts of these
structures (urea transporters have been found in the descending
limb of short loops of Henle (S. Nielsen, D. Terris, M. Hediger,
and M. Knepper, personal communication), and in descending
vasa recta [17]) enable a large fraction of the urea carried in the
ascending blood to be reintroduced in the descending vasa recta
Nitrogen sparing
4,
Minimize urea excretion
1
Protein supply
Excretion of excess
nitrogen
Minimize water requirement
for urea excretion
Make hypertonic urineRe-use urea nitrogen
(bacterial urease in digestive tract)
SheepRhhit
I Human
DogIRat ___
1600 Bankir et al: The real cost of urea excretion
0
c':s
a)0
a)
C.)
ci)C
0)
C)
a)
A
1.0
0
0.9
0)
0.8
cci
cci
0)
0
C
C
ci)
D
0.6
0.5
0.4
Inulin U/P ratio
E
a)
C.)C
cci
cci
a)
C)
cci
a)
100
80
60
40
20
0
70
60
50
• 40030
cci
20
10
C
.
.1 ••
S
If.
S
<—4
0 2 4 6
Urinary flow rate, ml/
D Human subject
8
mm
.
.
• •.S • .5 •.
•.S
.&.I5 • •
S,•..
• •
•.
.
••
• S
.
•
.< >-
0 20 40 60
Urinary flow rate, pJ/min
Rats
10
80 100
Fig. 2. Influence of urinary concentrating activity on urea clearance or fractional excretion in the Smithian Era (A, B, and C) and in the 1990s (D). A and
B are reproduced from [4]. C and D are reproduced (with slight modification) from [3]. C is redrawn from data by Van Slyke [26], and D is adapted
from data by Bankir et al [291. The double arrows in C and D indicate the range of urine flow rate observed in normal circumstances.
and in the descending branch of the loops. This creates an
intrarenal urea recycling process that returns part of the reab-
sorbed urea to the inner medulla and thus minimizes the loss of
urea from the medullary osmotic gradient (Fig. 3A). This V2-
dependent intrarenal urea recycling (IUR) has been well charac-
terized in several species and represents an essential step of the
urinary concentrating mechanism [18—201.
The vasopressin-induced IUR has at least two major (and
dose-dependent) consequences on renal function. (1) It reduces
the efficiency of urea excretion since it diverts from being excreted
part of the urea moving down in the CD. (2) It brings a higher
amount of urea to flow in the loops of Henle, distal tubule, and
CD. These facts are well illustrated by the elegant study of
Armsen and Reinhardt, who examined the fraction of urea
remaining in the urine and in various points of the nephron by
micropuncture in rats in which UCA was deliberately varied over
a wide range [21]. As shown in Figure 3B, wide variations in
urinary concentrating activity, indicated in abcissa by the urine to
plasma inulin concentration ratio, do not affect the delivery of
urea at the end of the proximal tubule accessible to micropunc-
ture. At all levels of urinary concentration, about 50% of the
filtered urea is reabsorbed upstream of this point. In contrast, with
increasing UCA, the fraction of urea recovered in the urine
progressively decreases (down to 20%), whereas that found in
the early accessible distal tubule increases progressively (up to
100%). That urea is added along the loop of Henle is clearly
shown by the fact that its delivery in the distal tubule largely
exceeds the amount of urea remaining in the late proximal tubule
(102% and 53% of the filtered amount, respectively, for UIP,1
of 250 to 400).
While the consequences of urea substraction from the CD have
been well analyzed (fall in Curea and FEurea; see above), the
consequences of an increased flow of urea in the ascending limb
of the loops has not been systematically evaluated. Micropuncture
studies performed in the seventies showed that urea concentration
in the early distal tubule of the rat may vary according to the level
of urinary concentration (and thus to the intensity of urea
recycling) in quite a large range (from 20 to 80 mmol/liter).
Vasopressin and urea are mutually dependent and are both
indispensable for urea accumulation in the renal medulla as a
result of the IUR. Accumulation of urea in the medulla does not
take place when either vasopressin is absent (as in Brattleboro
rats genetically devoid of vasopressin [22]) or urea excretion is
very low (as in rats fed a low protein diet [23]). Noteworthy is the
fact that vasopressin stimulates urea synthesis in the liver (togeth-
er with gluconeogenesis). Hepatocytes are well equiped with
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Fig. 3. A. Pathway of vasopressin V2-dependent urea recycling in the mammalian kidney. For simplicity, only one nephron is shown with a "composite"
thin limb. Actually, urea re-entry into thin limbs probably takes place in the descending thin limbs for short looped-nephrons and in the ascending thin
limb for long looped-nephrons. Not shown, urea is also returned to the inner medulla by countercurrent exchange between ascending and descending
vasa recta. Numbers indicate the range of urea concentrations observed in various points of the nephron, and in plasma and urine. Abbreviation AVR
is ascending vasa recta. B. Fraction of the filtrered urea recovered in late proximal and early distal tubules and in urine, according to changes in urinary
concentrating activity (indicated by the concentration of inulin in urine with respect to plasma). Drawn from data in [21].
vasopressin Vi receptors and the liver has actually been used for
purification and cloning of this receptor (see relevant references
in [24]). The functional significance of this hepatic action of
vasopressin (not yet evaluated in vivo) could be to deliver more
urea to the kidney in order to counteract the decreased excretion
due to enhanced reabsorption in the CD.
The vasopressin-induced urea recycling revealed by the increas-
ing fraction of filtrered urea present in the early distal tubule (Fig.
3) is accompanied by a vasopressin-dose-dependent increase in
the expression of mRNA of the urea transporter present in the
collecting duct and thin descending limbs. This increase is ob-
served both in the outer and the inner medulla, and concerns only
the short but not the long transcript of this gene [8, 25].
Maintenance of urea excretion in the face of UCA -dependent
decrease in fractional excretion
Even if the intrarenal urea recycling was not known in the times
of Homer W. Smith, the flow-dependency of urea excretion was
well characterized [1, 4, 11, 26]. However, intriguingly, little
attention has been given to the mechanism by which the kidney
can ensure an adequate urea excretion in the face of wide
differences in the efficiency of urea excretion within the physio-
logical range of urinary flow rates (a 3-fold range; Fig. 2). To our
knowledge, this question is still not addressed in current nephrol-
ogy textbooks (and the flow dependency of urea excretion is no
longer even emphasized). Obviously, a greater filtration of urea is
required when urine flow rate decreases and FEurea declines for
sustained periods of time. This can theoretically be achieved
either by a compensatory increase in plasma urea concentration
(Purea), or by an increase in GFR, or by a combination of both.
The general belief is that an increase in urea is the normal and
only consequence of the vasopressin-dependent reduction in the
efficiency of urea excretion. Actually, this proved to be wrong.
Several recent studies have convincingly shown that GFR (as well
as kidney weight in chronic situations) does increase with increas-
ing urinary concentrating activity [27—30; reviewed in 24], thus
limiting the rise in urea [291.
To re-evaluate the influence of chronic alterations in urine
concentrating activity on 'urea and GFR, we have recently per-
formed the following experiment [31]. Adult male Sprague-
Dawley rats living in metabolic cages were submitted for one week
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to one of three different levels of UCA. Low UCA was induced by
increasing water intake (mixing a given amount of dry powdered
food in an agar gel bringing 1.6 ml water per g food), and high
UCA by chronic i.p. infusion of 220 ng/day dDAVP (a selective
V2 agonist of AVP). High-UCA rats and control rats ate the same
quantity of dry food and dry agar as Low-UCA rats (the amount
provided being slightly lower than the spontaneous intake) and all
rats had free access to drinking water. The only difference
between groups thus concerned the water intake-vasopressin axis.
Radiolabeled 14C-inulin was infused chronically by osmotic
minipumps. Urine was collected and blood samples taken during
the last three days. This protocol produced mean 24 hours Usm
ranging from 500 and 3,500 mOsmlkg H20 without inducing any
disturbance in body fluids or plasma osmolality. As shown in
Figure 4A, GFR was markedly and positively correlated with
urine osmolality (U0sm). GFR was 31% higher for Uosm = 1,500
mOsm/kg H20 than for U0sm = 500 mOsm/kg H20. FEurea was
inversely related to Usm, as expected. urea increased from 4.3
0.2 m in low-UCA to 7.8 0.3 m in high-UCA. Because of the
flow-dependent fall in Curea, this increase would have been much
more intense had GFR failed to rise in high-UCA rats [31].
Similar influence of alterations in protein intake and in urinaty
concentrating activity
In young healthy volunteers, Lew and Bosh evaluated the
relationship between protein intake (deduced from daily urea
excretion), and creatinine clearance [32]. The results of this study
as well as the associated changes in urea (S.Q. Lew and J.P. Bosh,
personal communication) are depicted in Figure 4B. Both GFR
and plasma urea rose with increasing urea excretion.
Figure 4 reveals a striking parallelism in the influence on 1urea
and GFR of chronic alterations in protein intake on the one hand,
and of the chronic stimulation of urinary concentrating activity on
the other hand. Other similarities between the protein- and
vasopressin-induced changes in renal function have recently been
reviewed by Bankir and Kriz [24]. Why are the two situations
inducing so similar influences? In both situations, a rise in urea
may be expected to occur, either because more urea is synthetized
(HP feeding) or because urea is excreted less efficiently (vasopres-
sin). In both situations, this rise in urea is minimized by a
significant increase in GFR which delivers more urea to the renal
tubule. In both situations also, a marked kidney hypertrophy
develops (Fig. 5; see review and data in [24]). Is the same
mechanism involved in the two cases?
Bouby et a! showed that the influence of protein on kidney
function critically depends on the presence of vasopressin. The
rise in GFR is blunted and renal hypertrophy absent when high
protein diet (32% = HP vs. 10% casein = LP) is fed to
Brattleboro rats with hereditary diabetes insipidus. In these rats,
urea was 4.2 times higher in HP- than in LP-rats [33]. In contrast,
in normal rats with the same difference in protein intake, 1urea was
only 1.8-fold higher in HP-than in LP-rats (see Table 14-3 in [3]).
On the other hand, plasma vasopressin concentration is increased
after a single protein meal or on a high protein diet [34—37].
These findings strongly suggest that vasopressin plays a significant
role in the protein-induced increase in GFR, even if other
hormones (like glucagon or angiotensin II) are undoubtedly also
involved.
A significant rise in GFR is known to occur even after a single
large protein meal. Is a significant rise in GFR also observable
after short-term changes in UCA? In rats, results shown earlier by
us [29] and recent observations (H. Martin and L. Bankir,
manuscript in preparation) suggest it is the case. In humans, this
seems to be also the case, as appears from a few studies. (1) In
healthy volunteers infused with physiologic levels of vasopressin
for two hours after an initial water diuresis, Andersen et at
observed that C. rose significantly from 159 to 204 mI/mm along
with a marked increase in U0sm and a fall in FEurea [38]. (2) In
healthy volunteers, after 14 hours of abstinence of fluid intake, the
administration of a selective non-peptide vasopressin V2 antago-
nist (OPC 31260) induced a fall in CCr from =170 to =130 ml/min
(this fall was sustained for five 30-mm periods, but did not reach
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statistical significance because of an unusually high SEM in one of
the two control periods) [391. (3) Hadj-AIssa et al observed that
GFR and creatinine clearance were both 10% higher in healthy
volunteers during low hydration than when the same subjects were
studied during water diuresis [37].
UCA-dependent regulation of GFR: Proposed mechanism
The results shown above reveal that vasopressin and the
ensuing concentrating activity developed by the kidney are re-
sponsible for an increase in GFR in rats and probably also in
humans. Even if this new finding needs further confirmation,
several questions arise. By which mechanism does vasopressin
influence renal hemodynamics? What is the functional relevance
of this influence in every day life?
Possible mechanism explaining the vasopressin + urea-dependent
increase in GFR
The rise in GFR observed with increasing osmolality is not a
direct effect of vasopressin since it requires hours or days to he
detectable [27, 29, 381. The vascular Vi effects of vasopressin are
not required for this influence because chronic infusion of the V2
agonist dDAVP increases GFR in rats (see above). The mecha-
nism by which vasopressin influences GFR is thus likely secondary
to the V2-mediated effects of vasopressin on the renal tubule. We
propose that it results from an influence of urea recycling on the
intensity of the tubuloglomerular feedback (TGF).
As explained above, the combined—and spacially partly disso-
ciated—actions of vasopressin on the collecting duct's permeability
to water and urea initiate an intrarenal recycling of urea, which
adds a significant amount of urea to that already delivered to the
loop of Henle. As a result, the composition of the fluid flowing in
the thick ascending limb, and passing by the macula densa, is
enriched in urea compared to other solutes. This situation is very
Fig. 5. Similar consequences of high protein
intake and high urinaty concentrating activity on
the kidney.
similar to that observed in rats fed a high protein diet. In their
micropuncture study, Seney, Persson and Wright observed that
sodium and chloride concentrations in early distal tubular fluid
(the closest accessible point to the macula densa) were signifi-
cantly lower in HP than in LP rats, thus accounting for a lower
"signal" at the macula densa and a depressed TGF (Fig. 6) [40].
This observation at least in part explains the intrarenal mecha-
nism by which GFR is increased on a high protein diet, Interest-
ingly, these authors also measured osmolality in the same samples
of fluid from the early distal tubule. This osmolality was exactly
the same in HP and LP rats and amounted 150 mOsm/kg H20,
about twofold lower than that of plasma and surrounding inter-
stitium (Fig. 6). This means that another solute must account for
the 40 m difference in [total osmoles — (Na + Cl)1 observed in
the two dietary conditions. As explained earlier [41], this solute
can only be urea, the only solute that could exhibit changes of such
a magnitude, according to the level of protein intake.
As explained elsewhere [29], it is not assumed that urea itself
influences TGF. However, the presence of urea, an osmotically
active solute, can probably influence the capacity of the TAL to
dilute sodium chloride with respect to plasma. The limiting factor
for dilution of tubular fluid in the TAL is usually thought to be the
transepithelial difference in Na and Cl concentration. A "static
head" is reached when the passive backflux of these ions (increas-
ing with the magnitude of this transepithelial difference) exactly
compensates the active reabsorption. The observation of Seney,
Persson and Wright [40], recalled above, suggests that the limiting
factor for dilution in the TAL could be the transepithelial
difference in osmolality rather than that in NaCI concentration.
The identical tubular fluid osmolality seen in the two situations
suggests that some water leakage from the TAL (occurring when
the transepithelial difference in osmolality becomes too high),
rather than, or in addition to NaCI backdiffusion, limits the
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Fig. 6. Composition of fluid from the early distal tubule in rats fed a low
(open 5ymbols) or a high (closed symbols) protein diet for 10 days. Adapted
from [401.
diluting capacity of the TAL, and thus the intensity of the "signal"
perceived by the macula densa. Micropuncture experiments per-
formed in rats during different states of diuresis (and thus
different intensity of intrarenal urea recycling) confirm this pos-
sibility, since they show that the osmotic pressure of early distal
tubule fluid varies in a much narrower range than does the sodium
concentration at the same site [42]. A number of other indirect
arguments supporting this hypothesis have been presented in a
previous report [29]. New experiments designed to evaluate
simultaneously osmolality, Na, Cl, and urea concentrations in the
fluid of the early distal tubule under different levels of UCA are
needed to confirm the validity of the mechanism proposed here.
Experiments investigating the influence of variable concentrations
of urea (within a reasonable range) added to the perfusate, on the
diluting capacity of the cortical TAL would also be informative.
That the V2-dependent IUR is involved in the control of GFR
may explain the changes in GFR seen in two different conditions,
papillectomy, and severe burns. Several investigations have eval-
uated the influence of renal papillectomy on various aspects of
renal function (response to ANF, to saline loading, hypertension,
etc.). In eight such reports in which GFR data are available, a 20
to 40% fall in GFR is observed in papillectomized kidneys (which
had also lost part of their urinary concentrating acitivity) in the
absence of any sign of renal failure [reviewed in 24]. This can be
best explained by the fact that intrarenal recycling of urea was
suppressed by removal of the tip of the papilla (the starting point
of this recycling). As a result, UCA was impaired, filtered urea
was excreted more efficiently, and no urea addition occurred in
the loops of Henle (susceptible to modify indirectly the TGF
signal as explained above).
The very high GFR observed in burned patients [43] may result
from a markedly enhanced V2-dependent IUR because this
condition is characterized by the simultaneous increases in vaso-
pressin secretion and in urea excretion (due to intense protein
breakdown and to catabolism of exogenously infused amino acids;
see relevant references in [291).
Functional relevance of the vasopressin-urea-induced rise in GFR
One main consequence of the similar increase in GFR occur-
160 o ring with high protein intake or high UCA is to limit the rise in
1urea that results from either the increased synthesis of urea by the
140 liver in the first case, or the less efficient urea excretion in the
second case. Why limit this rise in Purca? It is usually believed that
120 urea itself is not toxic and that high circulating levels of urea areE well tolerated. However, several studies suggest that this is not the
case and that urea has indeed adverse effects in vivo, after
100 prolonged exposure. (1) Sustained intravenous infusion of urea in
normal dogs, achieving levels encountered in subjects with mod-
80 erate renal failure, were shown to produce a train of symptoms
analogous to that found in uremia [44]. (2) In chronically dialyzed
60 patients, addition of urea to the dialysate for several weeks
induced malaise, vomiting, bleeding, and headache when urea
concentrations in the dialysate exceeded 300 mg/100 ml (50 mM)
[45]. (3) In binephrectomized dogs undergoing peritoneal dialysis,
the addition of urea (160 mM) or potassium isocyanate (0.018 M)
halved the survival time of the dogs and induced hypothermia,
lethargy, anorexia, diarrhea and seizures before death [46]. More-
over, recent in vitro studies show that urea and/or urea-derived
cyanate (responsible for protein carbamylation), at concentrations
observed in CRF, impair several aspects of normal cell function,
such as decrease in the biological activity of various enzymes and
hormones, decrease in the immunologic potency of leukocytes
[47—52]. Urea has also recently been shown to affect concentra-
tion-dependently electrolyte transport in human erythrocytes
(33% fall in Na-K-2Cl cotransport for urea concentrations as low
as 45 mivt = 270 mg/dl) [53].
These findings show that, although urea is probably the least
toxic of all nitrogenous wastes, it is not harmless. This probably
explains why special mechanism(s) have evolved to limit the
intensity and duration of the rise in urca that could results from
either an abundant protein supply or a decreased efficiency in
urea excretion.
Why was the vasopressin-dependent rise in GFR not been
identified earlier?
Vasopressin was usually thought to have either no influence or
even to decrease renal hemodynamics. The results we have
obtained and those found in a few other studies suggest that
vasopressin actually increases GFR [27, 29, 31, 38]. It is interest-
ing to analyze why this influence has not been disclosed more
clearly ealier. First, this effect is slow to appear and cannot reach
a detectable intensity after just an hour of infusion of exogenous
vasopressin, especially if the control condition was an intense
diuresis that completely washed out urea from the inner medulla.
Urea accumulation in the medulla is known to be a relatively slow
process [22, 54, 55]. Second, when endogenous vasopressin is
increased by dehydration, the normal fluid balance is perturbated
in such a way that other mechanisms, mainly oriented towards
water conservation, come into play to reduce GFR and further
limit the risk of water loss. As illustrated in Figure 7, the
mechanism ensuring the best compromise between the opposite
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Fig. 7. Normal and abnormal situations in the regulation of body fluid volume and tonicity. The influence of the urinaly concentrating activity on GFR
is probably detectable only within the narrow range of physiological regulation in which the normal interplay between vasopressin and thirst is preserved.
needs of water conservation and urea excretion operates only
within the physiological range of body fluid regulation, the only
range in which the normal interplay between vasopressin and
thirst takes place so that plasma sodium concentration and
osmolality remain within physiological limits. Outside these limits,
the priority goes to preserving water balance in one way or the
other, living in the second place the need to excrete nitrogen
wastes.
Urea excretion: Cheap or expensive?
Contrary to the usual belief, urea excretion is "expensive" for
the kidney. The first expense of the body to excrete nitrogen
wastes in the form or urea is the energy used for its synthesis in the
liver. No less than four phosphate bonds derived from three ATP
molecules are needed for the synthesis of each urea molecule.
Accordingly, if carbohydrates and proteins are "isocaloric" chem-
ically, they are not so biologically in mammals, because the caloric
supply derived from protein oxydation is amputated by the
energetic cost of urea synthesis.
Because urea clearance is usually lower than GFR, and because
plasma urea concentration is relatively low (25-fold lower than
that of sodium), a huge amount of plasma needs to be filtered
("30-fold the total plasma volume per day) to excrete urea (and
probably several other substances that have a low plasma level and
are not secreted actively, such as creatinine, sulfate, and phos-
phate, etc.). Thereafter, most of the electrolytes and water, and all
low molecular weight metabolites (glucose, amino acids) need to
be reabsorhed with as little urea as possible to dispose of urea in
a relatively low volume of water and without losing precious
constituents. This reabsorption requires an intense metabolic
activity and consumes most of the oxygen burned in the kidney.
The rise in GFR observed after protein intake or stimulation of
urinary concentrating activity further increases the "cost" of urea
excretion in two ways. It aggravates the risk of pressure/flow-
dependent glomerular aging [561 and it increases the energetic
demand at the tubular level to reabsorb the extra solutes filtered.
A high GFR is thus the price to pay for urea excretion with an
efficient water conservation in mammals.
Consequences of the UCA-dependent regulation of GFR
Because of the similarity underlined above, and of the similar
mechanism that may be involved in both situations, UCA likely
exerts a permanent influence on GFR, as does the protein intake.
Large inter-individual variations in the spontaneous tendency to
concentrate urine are observed. In 50 normal subjects of both
sexes, mean 24 hour U0 varied between 250 to 1,000
mOsm/kg H20 and was quite reproducible from day to day (L.
Bankir, unpublished observation), as was vasopressin secretion
[57]. Accordingly, for an equivalent protein intake, GFR may be
expected to be higher in subjects who exhibit a high urine
concentration than in those with a low urinary concentration.
Confounding factor in experimental studies
The influence of UCA on GFR might obscure the influence of
other factors on renal hemodynamics. In our attempts to elucidate
the mechanism by which glucagon increases GFR, we have first
observed that this hormone increases simultaneously urea synthe-
sis by the liver and urea excretion by the kidney, together with free
water reabsorption [58]. Subsequently, we have established that
the intensity of the glucagon-induced rise in GFR was markedly
dependent upon the simultaneous changes occurring in UCA. The
rise in GFR tended to be smaller or was even absent when U/Purça
declined during the experiment [591. Changes in UCA may thus
represent a confounding factor in experiments designed to inves-
tigate the regulation of renal hemodynamics. A possible rise in
GFR induced by a given factor under study might be blunted if a
simultaneous decline in UCA depresses GFR at the same time.
Investigations of renal function in humans
Most studies of renal function in humans are carried out after
induction of a high diuresis. In the "Smithian Era" this was
designed to reach the maximal Curca used as an index of renal
function. The present justification is mostly technical: a high urine
flow rate ensures more complete urine collections. Intense water
diuresis is a condition rarely experienced in everyday life. In this
situation, urea excretion is efficient but the kidney must intensely
reabsorb other solutes so as to avoid electrolyte loss. In opposition
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to this, in normal conditions when vasopressin secretion is not
abolished, the kidney needs to minimize the reabsorption of all
the solutes that are excreted in a concentrated urine.
Although a number of interesting and pertinent observations
have been obtained in water diuretic subjects, one might wonder
whether some crucial aspects of normal renal function might not
be perturbated in this condition and thus remain undetectable
with this experimental setting. Moreover, one might also ask
whether the response of the kidney to various experimental
factors might not be altered when the need to excrete water
becomes a priority, contrary to what occurs in usual life. Certainly,
more investigations are needed in humans, to evaluate the
influence of water diuresis of variable intensity on GFR and on
other aspects of renal function.
Clinical situations
Diabetes mellitus. The vasopressin-urea dependent increase in
GFR could play a role in the hyperfiltration seen in diabetes
mellitus because both vasopressin plasma level [60, 611 and
protein catabolism (and thus urea excretion) are increased in this
condition.
Chronic renal failure. In chronic renal failure, UCA declines
progressively [62]. However, it is well preserved when free water
reabsorption is expressed per unit GFR. This means that each
remaining nephron's concentrating activity is not decreased. As
stated above, this concentrating activity is responsible for a certain
degree of hyperfiltration. This certainly explains: (1) why an
increase in water intake or the chronic infusion of a selective
vasopressin V2 receptor antagonist reduced proteirsuria and inci-
dence of glomerulosclerosis in rats with chronic renal failure [63,
641; (2) why hyperfiltration did not occur following renal mass
reduction in Brattleboro rats [65]; and (3) why a high protein
intake was not deleterious, when chronic renal failure was induced
by lithium intoxication, which compromizes the urinary concen-
trating ability [66]. According to these observations, it should be
as beneficial to depress the spontaneous tendency to concentrate
urine in patients with CRF as it is to reduce protein intake (and
the effects of the two should be additive). One should not,
however, induce the need to excrete free water, which could also
be a burden to the diseased kidney. The objective is to bring
urinary osmolality close to isotonicity. This could be achieved
either by increasing appropriately fluid intake of by using specific
antagonists of V2 vasopressin receptors [39, 67]. This therapeutic
approach would in any case improve urea clearance by increasing
urinary flow rate. It would also reduce the active transport in the
thick ascending limbs [24], which is another (probably related)
cause by which kidney damage is aggravated [68].
In conclusion, an increase in GFR is likely a normal adaptation
of the kidney to both protein consumption and urinary concen-
tration. This increase limits the rise in plasma urea concentration,
a favorable effect because urea is not totally harmless. The same
mechanism (change in TGF secondary to a more intense intrare-
nal recycling of urea) is probably involved in the two situations.
Further experiments are required to confirm the extent of the
indirect influence of vasopressin on renal hemodynamics and to
confirm if the proposed mechanism is actually correct.
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Appendix
Abbreviations are: UCA, urinary concentrating activity; V. urine flow
rate; Curca, urea clearance; FEur,,, fractional excretion of urea; 1urca,
plasma concentration of urea; U/Pura, urine to plasma urea concentration
ratio; Um, urine osmolality; CD, collecting duct; TAL, thick ascending
limb; TGF, tubuloglomerular feedback; JUR, intrarenal urea recycling;
HP and LP, high and low protein diets, respectively.
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